ArticleBreast cancer research : BCR2017

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.

Imke H Bartelink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.